Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination of Antibiotics for Previable Labour With Intact Membranes
NCT06572761Phase 3Not yet recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2026
- Primary completion
- May 2030
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ceftriaxone, clarithromycin and metronidazole in Preterm labor (PTL) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Perinatal composite outcome at 24 weeks. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
ceftriaxoneclarithromycinmetronidazole
03
Conditions
Preterm labor (PTL)
Beyond the preview
Go deeper on NCT06572761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06572761.